Overexpression of P-glycoprotein in tumor cells leads to multidrug resistance or enhances drug excretion, inhibiting the reaching of a pharmacologically active concentration, because of MDR1 regulation of pharmacokinetics of several anticancer drugs [30,31]. The gene discussed is ABCB1; the disease is neoplasm.